Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
10.69
+0.13 (1.23%)
Dec 29, 2025, 4:00 PM EST
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $41.58 billion as of December 29, 2025. Its market cap has increased by 100.00% in one year.
Market Cap
41.58B
Enterprise Value
79.87B
Revenue
53.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.69
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 41.58B, an increase of 609.54%. That is a compound annual growth rate of 5.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 42.08B | 113.73% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 748.72M |
| Elite Pharmaceuticals | 537.07M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 379.67M |
| CytoDyn | 353.44M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |